Business

Ark Make investments analyst breaks down Adaptive Biotechnologies and Invitae

Chad Robins, CEO of Adaptive Biotechnologies. Anjali Sundaram | CNBC Ark Make investments analyst Simon Barnett on Monday defined the agency’s strategy to what it